Cerus Corporation

Healthcare · Medical Devices · United States

Last price 2.28 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 459.48M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma do...